Literature DB >> 16177649

The effect of sevelamer on tacrolimus target levels.

Monika Merkle1, Markus Wornle, Harald D Rupprecht.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16177649     DOI： 10.1097/01.tp.0000172220.41719.31

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  4 in total

1.  Exploring co-dispensed drug use in patients on sevelamer or polystyrene sulfonate to identify potential novel binding interactions: a cross sectional in silico study : Potential novel binding interactions with resins.

Authors:  I R F van Berlo-van de Laar; I Prins-Can; C C M Schuiling-Veninga; K Taxis; F G A Jansman
Journal:  Int J Clin Pharm       Date:  2021-11-30

Review 2.  Immunotherapy in elderly transplant recipients: a guide to clinically significant drug interactions.

Authors:  Dirk R J Kuypers
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

Review 3.  Update and critical appraisal of sevelamer in the management of chronic renal failure.

Authors:  Jacob Grinfeld; Akimichi Inaba; Alastair J Hutchison
Journal:  Open Access J Urol       Date:  2010-09-02

4.  Binding interactions with sevelamer and polystyrene sulfonate in vitro.

Authors:  Inge R F van Berlo-van de Laar; Ilona Prins-Can; Aliesa A de Lange; Katja Taxis; Frank G A Jansman
Journal:  Pharmacol Res Perspect       Date:  2021-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.